Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06164795 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sequential Therapies After Osteoanabolic Treatment

Study acronym: START
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 1, 2026 to Jun 1, 2027
    • Study completion date: May 2027 to Dec 2027
    • Collaborators expanded, about 38 words
    v4
  2. Primary completion date: Dec 2025 to Dec 1, 2026v3 Show 4 more changesShow less
    • Study sites: 9 to 8
    • Study completion date: Dec 2025 to May 2027
    • Interventions: Denosumab (Drug), Romosozumab (Drug), Teriparatide (Drug), Zoledronate (Drug) to Abaloparatide Injection (80 mcg) (Drug), Denosumab (Drug), Romosozumab (Drug), Teriparatide (Drug), Zoledronate (Drug)
    • Study description expanded, about 6 words
  3. Primary endpoint revised
    • Eligibility criteria shortened, about 7 words
    • Secondary endpoints revised (5)
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics
Trial Details
NCT Number NCT06164795
Lead Sponsor 424 General Military Hospital
Collaborators: Laikο General Hospital, Athens, 251 Hellenic Air Force & VA General Hospital, KAT General Hospital, Campus Bio-Medico University, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano, Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy, University of Siena
Conditions
(from sponsor)		 Osteoporosis, Postmenopausal
Related terms Osteoporosis, Postmenopausal
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov